Dr. Maria Paula Roberti

Dr. Maria Paula Roberti is an immunologist and translational researcher based in Heidelberg, Germany. She earned her PhD in Immunology at the University of Buenos Aires, where she focused on anti-tumor innate immunity. Currently, she leads the Translational Research in Immuno‑Oncology and Microbiome (TRIM) sub‑group at the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg, serving as senior research associate and deputy head of the Clinical Cooperation Unit Applied Tumor Immunity.

Her work investigates how the gut microbiome influences the efficacy of cancer immunotherapies and chemotherapy, with the goal of overcoming treatment resistance through personalized microbiome interventions and biomarker discovery. Leading projects like the Mucosome study and the FLORA trial, her team integrates translational patient data, functional assays, and preclinical models to identify mechanisms by which microbiota modulate anti-tumor immunity.

Dr. Roberti is a respected contributor to the field, with publications in top-tier journals including Science, Nature Medicine, and Cell Death & Differentiation, and holds leadership roles in several international clinical trials and research initiatives.